D-threo-Ritalinic Acid is a chemical compound used as an active pharmaceutical ingredient in the manufacture of pharmaceutical products. It is structurally related to dexmethylphenidate, a central nervous system stimulant employed in the management of attention deficit hyperactivity disorder (ADHD).
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 129389-67-9
Fulvestrant
active pharmaceutical ingredient
Alclometasone 21-propionate
corticosteroid active pharmaceutical ingredient
Milbemycin oxime
antiparasitic active pharmaceutical ingredient
Glucosamine Sulfate Potassium Chloride
active pharmaceutical ingredient
2-Phenyl-2-(piperidin-2-yl)acetic acid hydrochloride
Pharmaceutical intermediate
Ritalinik asit
pharmaceutical intermediate
L-threo-Ritalinic Acid
pharmaceutical intermediate for methylphenidate
D-erythro-Ritalinic Acid
research compound
(2R)-2-phenyl-2-[(2R)-piperidin-2-yl]acetic acid
INGSNVSERUZOAK-VXGBXAGGSA-N
C1CCN[C@H](C1)[C@@H](C2=CC=CC=C2)C(=O)O